About this trial
The investigators will evaluate a new powered neck exoskeleton in patients with amyotrophic lateral sclerosis (ALS) to understand whether this device allows adequate head range of motion and achieves satisfaction from users. In this small cross-sectional device feasibility study, participants will be enrolled from the ALS clinic at the University of Utah Hospital. After obtaining written consent, participants will perform tasks using the neck exoskeleton. Tasks include computerized tracking tasks and simulated activities of daily living. Breaks will be added between tasks to avoid fatigue. Head-neck kinematics will be recorded, and range of motion will be computed. Participants will also report their satisfaction of the device.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
ALS diagnosis and neck weakness
Disqualifiers
Any cognitive deficits or visual impairments that would prevent from safely using the device and completing the tasks.
Trial design
Single group
Treatments tested in this trial
powered neck exoskeleton
DeviceSubjects will use the powered neck exoskeleton to control their head-neck motion to complete tasks involving head-neck motions. The neck exoskeleton will be worn and controlled by the users to assist them during tasks.
Treatment groups
Trial outcomes
Primary outcomes
range of motion
head range of motion (relative to torso) in three anatomical planes
Sponsors and contacts
Click on the lead sponsor to view all of their trials.